Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
01/31/2023 | 55.28% | HC Wainwright & Co. | → $5 | Assumes | → Buy |
12/12/2022 | 55.28% | HC Wainwright & Co. | $7 → $5 | Maintains | Buy |
08/29/2022 | 117.39% | Canaccord Genuity | $5.5 → $7 | Maintains | Buy |
08/18/2022 | 117.39% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
08/04/2022 | 86.34% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
03/25/2022 | -13.04% | Canaccord Genuity | → $2.8 | Initiates Coverage On | → Buy |
06/27/2019 | — | Craig-Hallum | Downgrades | Buy → Hold |
What is the target price for HIVE Blockchain Techs (HIVE)?
The latest price target for HIVE Blockchain Techs (NASDAQ: HIVE) was reported by HC Wainwright & Co. on January 31, 2023. The analyst firm set a price target for $5.00 expecting HIVE to rise to within 12 months (a possible 55.28% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HIVE Blockchain Techs (HIVE)?
The latest analyst rating for HIVE Blockchain Techs (NASDAQ: HIVE) was provided by HC Wainwright & Co., and HIVE Blockchain Techs their buy rating.
When is the next analyst rating going to be posted or updated for HIVE Blockchain Techs (HIVE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HIVE Blockchain Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HIVE Blockchain Techs was filed on January 31, 2023 so you should expect the next rating to be made available sometime around January 31, 2024.
Is the Analyst Rating HIVE Blockchain Techs (HIVE) correct?
While ratings are subjective and will change, the latest HIVE Blockchain Techs (HIVE) rating was a with a price target of $0.00 to $5.00. The current price HIVE Blockchain Techs (HIVE) is trading at is $3.22, which is within the analyst's predicted range.